Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 116 | 227 | 79 | 100 | 198 |
Cost of Goods | 9 | 4 | 4 | 3 | 3 |
Gross Profit | 107 | 222 | 75 | 98 | 195 |
Operating Expenses | 1,405 | 1,421 | 1,250 | 1,224 | 1,313 |
Operating Income | -1,290 | -1,194 | -1,171 | -1,124 | -1,116 |
Interest Expense | 16 | 141 | 132 | 108 | 112 |
Other Income | -870 | -898 | -47 | 88 | -54 |
Pre-tax Income | -2,176 | -2,233 | -1,350 | -1,143 | -1,281 |
Income Tax | -45 | -49 | -41 | -27 | 49 |
Net Income Continuous | -2,131 | -2,184 | -1,309 | -1,116 | -1,330 |
Minority Interests | -285 | -335 | -62 | -38 | -115 |
Net Income | $-1,846 | $-1,849 | $-1,248 | $-1,078 | $-1,215 |
EPS Basic Total Ops | -0.90 | -0.90 | -0.60 | -0.70 | -0.60 |
EPS Basic Continuous Ops | -1.09 | -1.12 | -0.67 | -0.61 | -0.70 |
EPS Diluted Total Ops | -0.90 | -0.90 | -0.60 | -0.70 | -0.60 |
EPS Diluted Continuous Ops | -1.09 | -1.12 | -0.67 | -0.61 | -0.70 |
EBITDA(a) | $-1,281 | $-1,184 | $-1,160 | $-1,113 | $-1,101 |